This content is machine translated Atopic dermatitis as a door opener for an atopic cascade? AD trajectories: Summary of current findings Epidemiologic analyses and longitudinal studies show that the majority of infants affected by AD are symptom-free as adults, but in some, AD persists into adulthood. This is associated with an...…
View Post 6 min This content is machine translated Psoriasis: therapy with biologics and TYK-2-i Progress assessments based on current long-term and real-world data A broad spectrum of systemic agents is now available for the treatment of moderate to severe psoriasis. At this year’s DDG congress “Dermatology compact + practical”, various studies were presented...…
View Post 5 min This content is machine translated Severe asthma and CRSwNP Multidisciplinary collaboration between pneumology, allergology and ENT Severe eosinophilic asthma (SEA) and chronic rhinosinusitis with nasal polyps (CRSwNP) are overlapping clinical entities united by a common pathophysiological basis of type 2 inflammation. The frequent co-occurrence of these...…
View Post 7 min This content is machine translated Psoriasis in difficult localizations: Nail psoriasis IL-23 and IL-17 as a target – selected study findings Although nail psoriasis remains a challenge, considerable progress has been made in both diagnostic and therapeutic terms. This is reflected, for example, in current analyses of the GUIDE and ZODIPSO...…
View Post 5 min This content is machine translated Psoriasis: System therapies in everyday practice Current real-world data at a glance The better the efficacy of a systemic treatment, the higher the patient satisfaction, especially if the risk-benefit balance is favorable. This plausible correlation is impressively underpinned by current findings from...…
View Post 5 min This content is machine translated Moderate to severe atopic dermatitis Established and novel biologics – the therapeutic landscape is in flux Clinically, atopic dermatitis (AD) manifests itself through a polymorphic picture of efflorescences, with pruritus and xerosis in the foreground. In addition to the antibody therapies dupilumab, tralokinumab and lebrikizumab, which...…
View Post 6 min This content is machine translated Hidradenitis suppurativa: biologics reduce inflammatory processes Treatment recommendations depend on the severity and inflammatory activity Due to its phenotypic heterogeneity and multifactorial pathogenesis, hidradenitis suppurativa is a complex disease that can be difficult to treat. Fortunately, research has achieved significant breakthroughs in the recent past,...…
View Post 6 min This content is machine translated COPD: Tailor therapy to individual characteristics Risk of exacerbation correlates with the eosinophil count and other factors The severity of COPD is determined based on lung function values, exacerbation history and symptom burden. A triple combination with inhaled steroids (ICS) is recommended for patients with a high...…
View Post 6 min This content is machine translated Atopic dermatitis: proven therapeutic principles and innovations From healthcare research to precision medicine In Switzerland, around 20 percent of children are affected by atopic eczema, compared to 4-5 percent of adults. The disease burden of AD is considerable, which is also related to...…
View Post 11 min This content is machine translated COPD therapy Drug therapy – Update 2025 Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory multisystem disease caused primarily by inhaled noxious substances in combination with environmental factors and genetic predispositions. The presence of such a...… CME-Test
View Post 2 min This content is machine translated TREATswitzerland Register Evaluation of system therapies for AD In addition to conventional immunosuppressants, several monoclonal antibodies (biologics) and Janus kinase inhibitors (JAK-i) are now approved for the systemic treatment of atopic dermatitis (AD) in Switzerland. The primary objective...…
